cmrouth
Your Child May Qualify for Disability Benefits
The following article was written by Rachel Gaffney. If you would like additional information, you can contact Rachel at rsg@ssd-help.org.
Search
cmrouth
- Jun 2, 2020
- 1 min
Stanford Study on Immune Therapy Treatment of AT/RT
https://scopeblog.stanford.edu/2020/04/30/new-advances-toward-safely-targeting-immune-cells-to-pediatric-brain-tumors/
40 views1 comment
cmrouth
- Jan 24, 2020
- 1 min
For Families Facing Malignant Rhabdoid Tumors, Reasons to Hope (repost from DFCI)
Since 2008, Cure ATRT Now, has been funding ATRT targeted research at Dana Farber & St Jude’s hospital. This inspiring story is the...
43 views0 comments
cmrouth
- Nov 6, 2017
- 1 min
Epizyme Research Update
We continue to fight to find a cure for ATRT. This is a long & complicated fight but we are making progress, albeit slowly. This is the...
73 views0 comments
cmrouth
- Dec 31, 2015
- 1 min
Epizyme launches dosing program
Epizyme announces first patient dosed in global clinical program. Dana Farber Cancer Institute and Cincinnati Children's Hospital are the...
57 views0 comments
cmrouth
- Dec 30, 2015
- 1 min
New Research Posted
New research posted to the We Can Help -> Research section of the web site. Pitfalls in Diagnosing AT/RT: Experiences From the European...
22 views0 comments
Cure ATRT Now
- Oct 3, 2015
- 1 min
Welcome!
Welcome to the new Cure ATRT Now website. When we started Cure ATRT Now, it was just a few frightened parents frustrated by the scarcity...
45 views0 comments
cmrouth
- Sep 28, 2015
- 1 min
Epizyme European Cancer Conference Recap
This presentation contains a lot of information, much of it very technical. The study is not specific to AT/RT, but does include AT/RT...
25 views0 comments
cmrouth
- Aug 24, 2015
- 1 min
FDA Accepts Drug in Phase 1 study INI1-Negative Tumors, Including AT/RT
Epizyme, Inc. a clinical stage biopharmaceutical company creating novel epigenetic therapies for patients with cancer, today announced...
22 views0 comments
cmrouth
- Aug 6, 2015
- 1 min
What is AT/RT Cancer?
For those just learning about AT/RT, here is an helpful post from the Dana Farber Cancer Institute: http://blog.dana-farber.org/insight/2...
41 views0 comments
cmrouth
- Nov 20, 2014
- 1 min
Phase 1 Dose Escalation Shows Promise
Barcelona, Spain, November 20, 2014 – Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative...
18 views0 comments